Aldesleukin Unknown Status Phase 2 Trials for Metastatic Renal Cell Carcinoma Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01274273Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney Cancer